Selexipag Active Metabolite ACT-333679 Displays Strong Anticontractile and Antiremodeling Effects but Low β-Arrestin Recruitment and Desensitization Potential
John Gatfield(Idorsia (Switzerland)), Oliver Nayler(Actelion (Switzerland))
Cited by 35
Related Papers
Sphingosine 1-Phosphate (S1P) Receptor Agonists Mediate Pro-fibrotic Responses in Normal Human Lung Fibroblasts via S1P2 and S1P3 Receptors and Smad-independent Signaling
|Journal of Biological Chemistry|2013|98